People's poll shows confusion over biotechnology

McKenzie, Debora
July 1991
New Scientist;7/13/91, Vol. 131 Issue 1777, p14
Details the results of a survey conducted by the European Commission regarding attitudes on biotechnology. Capability of biotechnology to improve life; Nationalities of people who scored themselves highest in their understanding of biotechnology; Risks perceived by people who claimed they knew more about biotechnology; Link of biotechnology with other fields.


Related Articles

  • Public knowledge.  // New Scientist;7/13/91, Vol. 131 Issue 1777, p11 

    Comments on the results of a survey conducted by the European Commission on attitudes towards biotechnology in the European community. Data indicating that the countries whose citizens are best informed about genetic engineering are those in which opposition appears to have been strongest;...

  • US, EU harmony initiative. Fox, Jeff // Nature Biotechnology;Aug99, Vol. 17 Issue 8, p737 

    Reports on the launch of a Transatlantic Economic Partnership biotechnology pilot project by the government of the United States. Aim of the project to harmonize standards and reduce regulatory barriers through cooperation in conducting biotechnology product reviews; Goal of the project to...

  • EU expansion: enlarged horizons or false dawn? Sansom, Clare // Nature Biotechnology;May2004, Vol. 22 Issue 5, p501 

    The article focuses on prospects of the biotech sector of eight new Central European members formally entering the European Union on May 1, 2004. It looks mainly at prospects for biotech in the three largest of the candidate countries: Poland, Hungary and the Czech Republic. Despite enthusiasm...

  • Boost for biotech. Gopal, Kevin // Pharmaceutical Executive;Aug97, Vol. 17 Issue 8, p38 

    Reports on the European Parliament's approval of a European Union directive affecting the legal protection of biotechnology products. Pharmaceutical industry's support of the directive's approval; Proposal for the creation of a European Ethics Advisory Committee.

  • EU prioritizes genomics. Lou√ęt, Sabine // Nature Biotechnology;Apr2001, Vol. 19 Issue 4, p298 

    Reports on European Union's publication of grant-giving Framework VI program for 2003-2006, initiating two billion euro for genomics and health biotechnology as of April 2001. Aim of the program to develop collaborative research networks across Europe; Allocation of funds to biotechnology...

  • U.S., South American farmers unite to support biotech.  // Nebraska Farmer;Sep2012, Vol. 154 Issue 9, p126 

    The article focuses on the move of several farmers from different countries to support biotechnology in the European Union.

  • Europe approves patenting of biotechnological inventions. Watson, Rory // BMJ: British Medical Journal (International Edition);05/23/98, Vol. 316 Issue 7144, p1558 

    States that the legislation or law which will permit biotechnological inventions to be originated in the European Union (EU), were accepted by pharmaceutical companies in several patient groups. Information on the aims of the legislation; What the EU's measures were designed to do; Details on...

  • Agricultural microbial resources: private property or global commons? Kothamasi, David; Spurlock, Matthew; Kiers, E Toby // Nature Biotechnology;Dec2011, Vol. 29 Issue 12, p1091 

    The article discusses the challenges to agricultural microbial resource development. It details the lack of a consistent global patent regime and the debate over microbial ownership rights of agricultural microbes. It provides an overview of the status of microbial patents in the U.S. and the...

  • EU Prediction: Europe's Biotech Future Will Depend On Change. O'Donnell, Peter // BioWorld International;7/11/2007, Vol. 12 Issue 28, p3 

    The article reports on the prediction of the European Union that personalized medicine will be a reality by 2030, as a result of novel biotechnology drugs and regenerative medicine. An expert group assembled by Germany published a 20-year forecast of the perspectives for the bioeconomy. The...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics